title: Saturated fatty acids enhance osteoclast survival.
abstract: Hyperlipidemia and marrow fat are associated with lowering bone density in vivo, suggesting that lipid contributes to bone loss. Using bone marrow-derived macrophages, we investigated the effect of saturated fatty acids (SFA) on osteoclastogenesis. The level of free fatty acids and adiposity in bone marrow was significantly elevated in obese mice. SFA increased osteoclast (OC) survival by preventing apoptosis. SFA caused the production of MIP-1alpha and led to activation of nuclear factor (NF)-kappaB in the OC. The absence of Toll-like receptor 4 (TLR4) or myeloid differentiation factor 88 (MyD88) abolished the survival effect of SFA on OC.
authors.affiliation: Department of Biological Sciences (BK21 Program), University of Ulsan, Ulsan 680-749, Korea.
authors.forename: So-Ra
authors.initials: SR
authors.lastname: Oh
authors.forename: Ok-Joo
authors.initials: OJ
authors.lastname: Sul
authors.forename: Youn-Young
authors.initials: YY
authors.lastname: Kim
authors.forename: Hye-Jin
authors.initials: HJ
authors.lastname: Kim
authors.forename: Rina
authors.initials: R
authors.lastname: Yu
authors.forename: Jae-Hee
authors.initials: JH
authors.lastname: Suh
authors.forename: Hye-Seon
authors.initials: HS
authors.lastname: Choi
mesh_terms: D000818:Animals; D001853:Bone Marrow / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D054405:Chemokine CCL3 / Q000096:biosynthesis; D005227:Fatty Acids / Q000378:metabolism / Q000494:pharmacology*; D055786:Gene Knockout Techniques; D008297:Male; D051379:Mice; D053594:Myeloid Differentiation Factor 88 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D009765:Obesity / Q000378:metabolism; D010010:Osteoclasts / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D051197:Toll-Like Receptor 4 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism
chemical_list: D054405:Chemokine CCL3; D005227:Fatty Acids; D053594:Myeloid Differentiation Factor 88; C493487:Tlr4 protein, mouse; D051197:Toll-Like Receptor 4
references.citation: J Bone Miner Res. 2008 Nov;23(11):1722-30
references.pmid: 18597639
references.citation: J Immunol. 2002 Aug 1;169(3):1516-23
references.pmid: 12133979
references.citation: J Bone Miner Res. 2006 Dec;21(12):1907-12
references.pmid: 17002586
references.citation: J Immunol. 2004 Aug 1;173(3):2084-90
references.pmid: 15265944
references.citation: Endocrinology. 2008 Nov;149(11):5688-95
references.pmid: 18617622
references.citation: J Intern Med. 2007 Oct;262(4):408-14
references.pmid: 17875176
references.citation: Bone. 2005 May;36(5):840-53
references.pmid: 15794931
references.citation: J Clin Invest. 2001 Dec;108(12):1833-41
references.pmid: 11748267
references.citation: FASEB J. 2004 Aug;18(11):1282-4
references.pmid: 15208271
references.citation: J Periodontol. 2007 Mar;78(3):559-65
references.pmid: 17335381
references.citation: J Periodontol. 2006 Mar;77(3):350-6
references.pmid: 16512748
references.citation: Immunol Res. 2000;21(2-3):49-54
references.pmid: 10852101
references.citation: Cell Death Differ. 2003 Oct;10(10):1165-77
references.pmid: 14502240
references.citation: J Immunol. 2003 Apr 1;170(7):3688-95
references.pmid: 12646634
references.citation: J Biol Chem. 2001 May 18;276(20):16683-9
references.pmid: 11278967
references.citation: J Exp Med. 1992 Aug 1;176(2):485-94
references.pmid: 1380063
references.citation: J Biol Chem. 1998 Oct 23;273(43):28355-9
references.pmid: 9774460
references.citation: Bone. 2007 Jun;40(6):1581-7
references.pmid: 17409043
references.citation: J Lipid Res. 2006 Aug;47(8):1739-48
references.pmid: 16702601
references.citation: Endocrinol Metab Clin North Am. 2008 Sep;37(3):635-46, viii-ix
references.pmid: 18775356
references.citation: Infect Immun. 1996 Jul;64(7):2371-80
references.pmid: 8698454
references.citation: J Magn Reson Imaging. 2005 Aug;22(2):279-85
references.pmid: 16028245
references.citation: Immunity. 1998 Jul;9(1):143-50
references.pmid: 9697844
references.citation: Mol Cell Endocrinol. 2001 Apr 25;175(1-2):81-92
references.pmid: 11325518
references.citation: Osteoporos Int. 2005 Dec;16(12):1975-81
references.pmid: 16167087
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Blood. 2000 Jul 15;96(2):671-5
references.pmid: 10887133
references.citation: J Intern Med. 2006 Jun;259(6):598-605
references.pmid: 16704561
references.citation: J Biol Chem. 2007 Nov 30;282(48):35279-92
references.pmid: 17916553
references.citation: Exp Hematol. 2007 Jul;35(7):1100-8
references.pmid: 17588479
references.citation: J Clin Invest. 2005 May;115(5):1111-9
references.pmid: 15864338
references.citation: J Clin Pathol. 2002 Sep;55(9):693-8
references.pmid: 12195001
references.citation: J Clin Endocrinol Metab. 2004 Sep;89(9):4246-53
references.pmid: 15356016
references.citation: J Bone Miner Res. 2001 Jan;16(1):182-8
references.pmid: 11149483
references.citation: Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):e6-10
references.pmid: 14670933
references.citation: Endocr Rev. 1996 Aug;17(4):308-32
references.pmid: 8854048
references.citation: Immunity. 1999 Jul;11(1):115-22
references.pmid: 10435584